Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Trenkler

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
BMJ Open|July 2, 2017
Quality of life, treatment satisfaction and efficacy of non-biological systemic therapies in patients with plaque psoriasis: study protocol for a prospective observational studyChristine Fink, Timo E Schank, Nina Trenkler, et al.
Journal of Dermatological Science|May 14, 2017
The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cellsStephanie Oehrl, Hridayesh Prakash, Annette Ebling, et al.
The Journal of Dermatology|August 9, 2025
Long-Term Impact of Guselkumab on Skin, Sexuality, and Perceived Stigmatization in Patients With Psoriasis in Routine Clinical Practice: Week 76 Effectiveness and Safety Results From the Prospective German Multicenter G-EPOSS StudySascha Gerdes, Peter Weisenseel, Durdana Groß, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
BMJ Open|July 2, 2017
Quality of life, treatment satisfaction and efficacy of non-biological systemic therapies in patients with plaque psoriasis: study protocol for a prospective observational studyChristine Fink, Timo E Schank, Nina Trenkler, et al.
Journal of Dermatological Science|May 14, 2017
The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cellsStephanie Oehrl, Hridayesh Prakash, Annette Ebling, et al.
The Journal of Dermatology|August 9, 2025
Long-Term Impact of Guselkumab on Skin, Sexuality, and Perceived Stigmatization in Patients With Psoriasis in Routine Clinical Practice: Week 76 Effectiveness and Safety Results From the Prospective German Multicenter G-EPOSS StudySascha Gerdes, Peter Weisenseel, Durdana Groß, et al.
Pageof 1